William Howard - In Memoriam

William W. Howard, Ph.D., MBA, is the Founder and past Chairman of the Board of Directors and past President of Alitair Pharmaceuticals. Dr. Howard retired from Alitair in February 2019. Dr. Howard passed away in March 2020 and will be greatly missed.

Prior to starting the Company, Dr. Howard served as Senior Vice President of New Products and Business Development for Adams Respiratory Therapeutics, which is best known for the highly successful Mucinex® cough/cold product line. Adams was acquired by Reckitt Benckiser in January 2008 for $2.3 billion, nearly 7 times its fiscal 2007 sales. Dr. Howard first worked for Adams as a consultant in 2001 and later joined Adams in 2004 as a full-time employee after working on the initial commercialization strategy for Mucinex®. After Adams was acquired by global consumer goods powerhouse Reckitt Benckiser, Dr. Howard applied the lessons he learned, which culminated in founding Alitair and developing a strategy to develop a portfolio of products for the prescription market. Following his retirement in February 2019, Dr. Howard has no role on the Board or the Executive Team. Alitair stakeholders and shareholders are grateful to Dr. Howard for his commitment in driving the company forward and to his “Chief Idea Man” status within our sphere of engagement. We will never forget Bill and his contributions to Alitair.